510(k) Report

510(k) · Cleared

Cleared

Liquichek Ana Control, Eia Screen, Model 205

K984473510(k) TraditionalCleared Dec 22, 19986-day reviewClass II21 CFR 866.5100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad · LKJ Antinuclear Antibody, Antigen, Control

Cleared on Dec 22, 1998 as substantially equivalent to K954723 (Helix Diagnostics, Inc., 1995) after a 6-day review. Its family tree reaches back 1 generation to 1995.

Decided
Dec 22, 1998
Review
6 days
Class
Class II
Product code
LKJ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K954723 (1995). No later device cites it as a predicate yet.

  1. Root · 1 generation backK954723 Enzyme Immunoassay Ana Screening Test KitHelix Diagnostics, Inc. · 1995 · Recalled
  2. This deviceK984473 Liquichek Ana Control, Eia Screen, Model 205Bio-Rad · 1998
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K954723Enzyme Immunoassay Ana Screening Test KitHelix Diagnostics, Inc.19956
0 (this device)K984473Liquichek Ana Control, Eia Screen, Model 205Bio-Rad1998—
FIG. 1 — Lineage of K984473, 1995–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LKJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LKJ device

  1. #1 K210902 EliA Ro52, EliA Ro60score 4.0 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K954723Enzyme Immunoassay Ana Screening Test Kit
Summary page 1
…ol. Devices to Which Substantial Equivalence is Claimed Helix Enzyme Immunoassay Antinuclear Antibody Screening Test Kit Helix Diagnostics West Sacrament, California K954723 . Statement of Intended Use Liquichek ANA Control, EIA Screen is intended for use as an unassayed quality control to monitor en…
Helix Diagnostics, Inc.19956

Also cleared against K954723: 10 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • 10 other devices also cite its predicate K954723.

How does its category compare?

All LKJ devices

LKJ Antinuclear Antibody, Antigen, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LKJ

1in 2022

2008: 12009: 12012: 12022: 1
2007high 1 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LKJ

Too few LKJ 510(k)s in any year since 2007 to give a median.

Recalls per year · LKJ

1in 2019

2007: 12010: 72015: 12017: 12019: 1
2007high 7 (2010) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LKJ

2in 2018

2010: 22011: 172017: 22018: 2
2007high 17 (2011) · low 0 (2007)2025

MAUDE reports naming product code LKJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—10
20081—00
20091—00
20100—72
20110—017
20121—00
20130—00
20140—00
20150—10
20160—00
20170—12
20180—02
20190—10
20200—00
20210—00
20221—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

Liquichek ANA Control, EIA Screen is intended for use as an unassayed quality control to monitor enzyme immunoassay procedures for the screening of antinuclear antibodies (ANA).

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K984473: Liquichek Ana Control, Eia Screen, Model 205.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K984473

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026